Literature DB >> 19694614

Stimulation of human macrophages (THP-1) using Toll-like receptor-2 (TLR-2) agonist decorated nanocarriers.

Simon Heuking1, Sarah Adam-Malpel, Emmanuelle Sublet, Antonio Iannitelli, Antonio di Stefano, Gerrit Borchard.   

Abstract

The purpose of this study was to prepare and characterize nanocarrier systems, which allow the application of pDNA vaccines and adjuvants to mucosal vaccination. Chitosan from a vegetal source (Agaricus bisporus) and of GMP quality was used to synthesize the derivative 6-O-carboxymethyl-N,N,N-trimethylchitosan (CM-TMC). Toll-like receptor-2 (TLR-2) agonist, Pam(3)Cys, was synthesized and coupled to CM-TMC through a polyethylene glycol (PEG) spacer. Successively, Pam(3)Cys decorated nanocarriers were prepared by complexation with plasmid DNA (pDNA) expressing green fluorescence protein (GFP), and characterized with respect to their physicochemical properties and protection of the included plasmid against DNase I enzymatic degradation. In vitro studies using phorbol 12-myristyl 13-acetate (PMA) stimulated macrophage-like THP-1 (mTHP-1) cells were focused on cytotoxicity of both polymers and particles, and their potential to stimulate IL-8 release via the TLR-2 pathway. Our results showed that the TLR-2 functionalized pDNA nanocarriers have the ability to complex and to protect pDNA against enzymatic degradation. pDNA nanocarriers were of around 400 nm in size, and displayed a positive zeta potential of 27.9 +/- 1.6 mV. Chitosan, CM-TMC, and Pam(3)Cys-functionalized CM-TMC polymers displayed cytotoxicity on mTHP1 cells in a concentration-dependent manner, which decreased by 50-fold on complexation with pDNA. In addition, decorated pDNA nanocarriers induced IL-8 secretion by mTHP-1 macrophages, which was increased by 10-fold as compared to nondecorated carriers.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19694614     DOI: 10.1080/10611860903106034

Source DB:  PubMed          Journal:  J Drug Target        ISSN: 1026-7158            Impact factor:   5.121


  8 in total

1.  Activation of antigen-specific T cell-responses by mannan-decorated PLGA nanoparticles.

Authors:  Samar Hamdy; Azita Haddadi; Anooshirvan Shayeganpour; John Samuel; Afsaneh Lavasanifar
Journal:  Pharm Res       Date:  2011-05-11       Impact factor: 4.200

2.  The impact of nanoparticle ligand density on dendritic-cell targeted vaccines.

Authors:  Arunima Bandyopadhyay; Rebecca L Fine; Stacey Demento; Linda K Bockenstedt; Tarek M Fahmy
Journal:  Biomaterials       Date:  2011-01-22       Impact factor: 12.479

Review 3.  Delivery of host cell-directed therapeutics for intracellular pathogen clearance.

Authors:  Michael A Collier; Matthew D Gallovic; Kevin J Peine; Anthony D Duong; Eric M Bachelder; John S Gunn; Larry S Schlesinger; Kristy M Ainslie
Journal:  Expert Rev Anti Infect Ther       Date:  2013-10-18       Impact factor: 5.091

4.  Nanocarriers for DNA Vaccines: Co-Delivery of TLR-9 and NLR-2 Ligands Leads to Synergistic Enhancement of Proinflammatory Cytokine Release.

Authors:  Johanna Poecheim; Simon Heuking; Livia Brunner; Christophe Barnier-Quer; Nicolas Collin; Gerrit Borchard
Journal:  Nanomaterials (Basel)       Date:  2015-12-17       Impact factor: 5.076

Review 5.  Nanoengineering of vaccines using natural polysaccharides.

Authors:  Ana Sara Cordeiro; María José Alonso; María de la Fuente
Journal:  Biotechnol Adv       Date:  2015-06-03       Impact factor: 14.227

6.  Fate of TLR-1/TLR-2 agonist functionalised pDNA nanoparticles upon deposition at the human bronchial epithelium in vitro.

Authors:  Simon Heuking; Barbara Rothen-Rutishauser; David Olivier Raemy; Peter Gehr; Gerrit Borchard
Journal:  J Nanobiotechnology       Date:  2013-08-21       Impact factor: 10.435

7.  Novel NSAID-Derived Drugs for the Potential Treatment of Alzheimer's Disease.

Authors:  Ivana Cacciatore; Lisa Marinelli; Erika Fornasari; Laura S Cerasa; Piera Eusepi; Hasan Türkez; Cristina Pomilio; Marcella Reale; Chiara D'Angelo; Erica Costantini; Antonio Di Stefano
Journal:  Int J Mol Sci       Date:  2016-06-30       Impact factor: 5.923

8.  Ag85A DNA Vaccine Delivery by Nanoparticles: Influence of the Formulation Characteristics on Immune Responses.

Authors:  Johanna Poecheim; Christophe Barnier-Quer; Nicolas Collin; Gerrit Borchard
Journal:  Vaccines (Basel)       Date:  2016-09-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.